Basildon Hospital makes strides to ensure patient safety in point of care (POC) diagnostic testing

Roche cobas® IT 1000 software improves quality of patient information, ensures accuracy of testing, and provides immediate access to results for authorised staff

Myconostica’s MycAssay™ Aspergillus Kit Shows its Sensitivity in Serum

Myconostica announces the publication (White et al, J. Clin. Microbiol. 2011) of an evaluation of the analytical and preliminary clinical performance of its MycAssay™ Aspergillus kit for the diagnosis of Invasive Aspergillosis (IA) using serum samples. The trial tested 31 high risk haematology subjects. 10 patients were classified as having proven/probable IA and 21 as at risk of IA with a total of 170 samples. The sensitivity of the assay was >70% and the specificity >90%. This was a retrospective study with stored samples and the authors note that some degradation of the DNA was likely to have occurred so it is proposed that a prospective study would improve the assay sensitivity.

Myconostica Announces Publication of Trial Results with MycAssay TM Pneumocystis Kit

Manchester, United Kingdom, April 4, 2011 / b3c newswire / - Myconostica, specialising in rapid molecular diagnostic tests for life-threatening fungal infections, announces the publication ( Hauser et al, J. Clin. Microbiol.) of a multicentre prospective trial of its CE marked kit, MycAssay™ Pneumocystis for the detection of Pneumocystis jirovecii. The trial results compare well with clinical diagnosis using non-molecular methods and demonstrate the high sensitivity and specificity of the PCR diagnostic assay.

Point-of-care cardiac assays shorten turnaround times in emergency departments

Radiometer, the world-renowned provider of point-of-care blood gas analysers, has used its expertise in acute clinical testing to develop a compact and cost-effective immunoassay analyser for measuring critical biomarkers at the patient’s bedside. The AQT90 FLEX uses advanced technology to accurately measure a range of biochemical parameters, including Troponin I and Troponin T, at the point of patient care, ensuring a fast and accurate process for ruling-in or ruling-out patients for further assessment or urgent treatment.